APA

Bouman-Wammes E. W., van Dodewaard-De Jong J. M., Dahele M., Cysouw M. C. F., Hoekstra O. S., van Moorselaar R. J. A., Piet M. A. H., Verberne H. J., Bins A. D., Verheul H. M. W., Slotman B. J., Oprea-Lager D. E. & Van den Eertwegh A. J. M. (20180521). Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT. : Clinical genitourinary cancer.

Chicago

Bouman-Wammes Esther W, van Dodewaard-De Jong Joyce M, Dahele Max, Cysouw Matthijs C F, Hoekstra Otto S, van Moorselaar R Jeroen A, Piet Maartje A H, Verberne Hein J, Bins Adriaan D, Verheul Henk M W, Slotman Ben J, Oprea-Lager Daniela E and Van den Eertwegh Alfons J M. 20180521. Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT. : Clinical genitourinary cancer.

Harvard

Bouman-Wammes E. W., van Dodewaard-De Jong J. M., Dahele M., Cysouw M. C. F., Hoekstra O. S., van Moorselaar R. J. A., Piet M. A. H., Verberne H. J., Bins A. D., Verheul H. M. W., Slotman B. J., Oprea-Lager D. E. and Van den Eertwegh A. J. M. (20180521). Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT. : Clinical genitourinary cancer.

MLA

Bouman-Wammes Esther W, van Dodewaard-De Jong Joyce M, Dahele Max, Cysouw Matthijs C F, Hoekstra Otto S, van Moorselaar R Jeroen A, Piet Maartje A H, Verberne Hein J, Bins Adriaan D, Verheul Henk M W, Slotman Ben J, Oprea-Lager Daniela E and Van den Eertwegh Alfons J M. Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT. : Clinical genitourinary cancer. 20180521.